Georgia’s New AI Guardrail for Health-Coverage Reviews Takes Effect January 1, 2027

Effective January 1, 2027, Act 411 will permit AI-supported utilization review, but an artificial intelligence system, artificial intelligence, or other software tool may not issue an adverse determination to a patient until a natural person qualifying as a private review agent or a utilization review entity conducts a utilization review in which a clinical peer participates.

Georgia’s SB 444 became Act 411 when it was signed on May 5, 2026. The Act takes effect January 1, 2027.

When effective, the Act will add O.C.G.A. § 33-46-7.1 to Georgia’s insurance code. It does not prohibit artificial intelligence in utilization review. Instead, it will permit private review agents and utilization review entities to use artificial intelligence systems, artificial intelligence, or other software tools, provided that the systems or tools are part of a utilization-review plan that complies with Chapter 33-46 and rules and regulations adopted by the Insurance Commissioner. The tools may be used to automate tasks, reduce administrative burdens, participate in decision-making processes, and perform other lawful functions, subject to the Act’s restrictions.

The line the statute draws concerns adverse determinations.

Under the enacted text, AI systems, AI, and other software tools:

“shall not issue an adverse determination to a patient until a natural person qualifying as a private review agent or a utilization review entity conducts a utilization review in which a clinical peer participates.”

The statute also states that those systems and tools may not supersede the clinical peer’s judgment.

Chapter 33-46 defines an “adverse determination” as “a determination based on medical necessity made by a private review agent or utilization review entity not to grant authorization to a hospital, surgical, or other facility or to a healthcare provider’s office for admission, extension of an inpatient stay, or a healthcare service or procedure.” In this article, the term refers only to that statutory category, not to every coverage denial or adverse healthcare decision.

What the law does—and does not—say

The final as-passed text does not establish a general human-oversight rule for every use of AI in healthcare administration. The new Code section is written in Chapter 33-46 terms and must be read with that chapter’s applicability provisions, definitions, and exclusions.

When effective, the new section will permit private review agents and utilization review entities to use artificial intelligence systems, artificial intelligence, and other software tools within their utilization-review plans, subject to Chapter 33-46 and the Commissioner’s rules.

Those systems and tools may not issue an adverse determination to a patient until a natural person qualifying as a private review agent or a utilization review entity conducts a utilization review in which a clinical peer participates. They also may not supersede that clinical peer’s judgment.

For purposes of the new Code section, “artificial intelligence” means a machine-based system that can make predictions, recommendations, or decisions influencing real or virtual environments for human-defined objectives. The section separately defines an “artificial intelligence system” as an engineered or machine-based system that can receive information and use it to emulate a human cognitive process, including learning, generalizing, reasoning, planning, predicting, acting, or communicating.

January 1 is the operative date

Act 411 does not state a separate compliance deadline. Its operative date is January 1, 2027.

That gives private review agents and utilization review entities time to identify where AI or other software tools in their utilization-review plans issue adverse determinations to patients and whether their workflows provide for the required natural-person utilization review and clinical-peer participation before issuance. Other organizations should analyze applicability under current Chapter 33-46 rather than assume that the new section covers every healthcare workflow.

The new section should not be read in isolation. Before treating Act 411 as a complete implementation checklist, affected organizations should consult the current applicability provisions and definitions in O.C.G.A. Chapter 33-46, the applicable Georgia Insurance Commissioner rules, and any relevant agency guidance.

The central takeaway is straightforward: effective January 1, 2027, Georgia will expressly permit private review agents and utilization review entities to use AI and other software tools in covered utilization review, but the tools may not issue an adverse determination to a patient before the required natural-person utilization review with clinical-peer participation, and they may not supersede the clinical peer’s judgment.